Story perspectives

Supreme Court Lets Mail-Order Mifepristone Continue, FDA Reviews Safety

5/17/2026

Summary

Story summary

Supreme Court ruled providers may continue mailing mifepristone and supplying it to pharmacies while the case proceeds in lower courts.
Justices Clarence Thomas and Samuel Alito invoked the 1873 Comstock Act, warning its enforcement could jeopardize the reproductive-health supply chain.
The Food and Drug Administration launched a safety review of mifepristone, noting that without mail delivery patients would rely on misoprostol alone, prolonging abortions and increasing cramping.

1 of 1

Story summary

Supreme Court ruled providers may continue mailing mifepristone and supplying it to pharmacies while the case proceeds in lower courts.
Justices Clarence Thomas and Samuel Alito invoked the 1873 Comstock Act, warning its enforcement could jeopardize the reproductive-health supply chain.
The Food and Drug Administration launched a safety review of mifepristone, noting that without mail delivery patients would rely on misoprostol alone, prolonging abortions and increasing cramping.